 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Trial completion: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). (clinicaltrials.gov) - Aug 29, 2023
P2, N=131, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed
- ||||| New P2 trial: CPMP: A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (clinicaltrials.gov) - Aug 14, 2023
P2, N=10000, Recruiting, Sponsor: Eli Lilly and Company
- || LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Enrollment closed: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). (clinicaltrials.gov) - Aug 1, 2023
P2, N=125, Active, not recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Trial completion: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain (clinicaltrials.gov) - Jul 12, 2023
P2, N=138, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Trial completion: OA05: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain (clinicaltrials.gov) - Jul 12, 2023
P2, N=147, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Enrollment closed: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain (clinicaltrials.gov) - May 23, 2023
P2, N=125, Active, not recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- || LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Enrollment closed: OA05: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain (clinicaltrials.gov) - Apr 14, 2023
P2, N=125, Active, not recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || LY3857210 / Eli Lilly
Trial completion, Enrollment change: A Study of LY3857210 in Healthy Participants (clinicaltrials.gov) - Mar 1, 2023
P1, N=10, Completed, Sponsor: Eli Lilly and Company
Recruiting --> Active, not recruiting Recruiting --> Completed | N=25 --> 10
- ||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Enrollment open: OA05: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain (clinicaltrials.gov) - Dec 30, 2022
P2, N=125, Recruiting, Sponsor: Eli Lilly and Company
Recruiting --> Completed | N=25 --> 10 Not yet recruiting --> Recruiting
- ||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Enrollment open: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain (clinicaltrials.gov) - Dec 27, 2022
P2, N=125, Recruiting, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
Enrollment open: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). (clinicaltrials.gov) - Dec 9, 2022
P2, N=125, Recruiting, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
New P2 trial: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain (clinicaltrials.gov) - Nov 29, 2022
P2, N=125, Not yet recruiting, Sponsor: Eli Lilly and Company
- |||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
New P2 trial: OA05: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain (clinicaltrials.gov) - Nov 17, 2022
P2, N=125, Not yet recruiting, Sponsor: Eli Lilly and Company
- |||| LY3857210 / Eli Lilly, Asahi Kasei, RaQualia
New P2 trial: A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). (clinicaltrials.gov) - Nov 17, 2022
P2, N=125, Not yet recruiting, Sponsor: Eli Lilly and Company
- | LY3857210 / Eli Lilly
Trial completion date, Trial primary completion date: A Study of LY3857210 in Healthy Participants (clinicaltrials.gov) - Jul 21, 2022
P1, N=25, Recruiting, Sponsor: Eli Lilly and Company
Not yet recruiting --> Recruiting Trial completion date: Jun 2022 --> Sep 2022 | Trial primary completion date: Jun 2022 --> Sep 2022
- || LY3857210 / Eli Lilly
Enrollment open: A Study of LY3857210 in Healthy Participants (clinicaltrials.gov) - Apr 13, 2022
P1, N=25, Recruiting, Sponsor: Eli Lilly and Company
Trial completion date: Jun 2022 --> Sep 2022 | Trial primary completion date: Jun 2022 --> Sep 2022 Not yet recruiting --> Recruiting
- || LY3857210 / Eli Lilly
New P1 trial: A Study of LY3857210 in Healthy Participants (clinicaltrials.gov) - Mar 22, 2022
P1, N=25, Not yet recruiting, Sponsor: Eli Lilly and Company